Skip to content
Answer ALS
  • ABOUT USExpand
    • OUR MISSION
    • OUR TEAM
    • CAMPAIGNS
  • RESEARCHExpand
    • RESEARCH PROGRESS
    • RESEARCH APPROACH
    • UNDERSTANDING ALS
    • ALS MYTHS
  • NEWSExpand
    • ALL NEWS
    • PRESS RELEASES
    • EVENTS
  • DONATEExpand
    • BECOME A DONOR
    • STORE
Facebook Instagram X Linkedin YouTube
Answer ALS

Charlie Rose

Jay Fishman and Answer ALS
News | Videos and Broadcasts

Jay Fishman and Answer ALS

ByHamid Patel November 4, 2015December 12, 2025

Broadcast in November 2015: Jay Fishman, chairman and chief executive officer of Travelers, who was diagnosed with ALS—known as Lou Gehrig’s disease—joined by Dr. Jeff Rothstein to discuss the fatal illness.

Read More Jay Fishman and Answer ALSContinue

Stay up to date! Get our newsletter.

Answer ALS

Help Us Answer ALS

Empowering & Accelerating ALS Research Around the World

About Us

  • Our Mission
  • Our Team
  • Campaigns
  • Contact Us

Research

  • Understanding ALS
  • ALS Myths
  • Research Approach
  • Research Progress

News

  • News & Announcements
  • Get our Newsletter

Donate

  • Become a Donor
  • Store
Neuromine Access

Contact Us

2021 Lakeshore Dr, Suite 304
New Orleans, LA 70122
info@answerals.org

Facebook Instagram X Linkedin YouTube

© Answer ALS. All rights reserved.

Data & Technology

Harnessing Big Data with Advanced Analytics Neuromine is one of the world’s most robust and comprehensive ALS data resources, integrating multi-omics, clinical, and cellular datasets, while also linking to coordinating iPSC lines, biosamples, and other large-scale data platforms with analytic tools to maximize discovery and collaboration.

Multi-Omnics Analysis

Comprehensive Biological Data Integration Making a comprehensive multi-omics datasets available that integrates genomics, transcriptomics, proteomics, epigenomics, and iPSC-derived motor neuron data that is freely accessible for analysis.

IPS Cells & Motor Neurons

Generated 1,000 Participant-Derived Cell Lines Learn More about how to access 1,000 iPSC lines through our partners at the Cedars-Sinai Biomanufacturing Center

Clinic & enrollment

Leading Clinics Engaged to Complete Enrollment Enrollment in the Answer ALS program is complete, but you can Learn More about connected programs like Champion Insights, ALS Therapy Development’s ARC Program

  • ABOUT US
    • OUR MISSION
    • OUR TEAM
    • CAMPAIGNS
  • RESEARCH
    • RESEARCH PROGRESS
    • RESEARCH APPROACH
    • UNDERSTANDING ALS
    • ALS MYTHS
  • NEWS
    • ALL NEWS
    • PRESS RELEASES
    • EVENTS
  • DONATE
    • BECOME A DONOR
    • STORE
Facebook X Instagram Linkedin
Search